Crocamo, S.; Binato, R.; dos Santos, E.C.; de Paula, B.; Abdelhay, E.
Translational Results of Zo-NAnTax: A Phase II Trial of Neoadjuvant Zoledronic Acid in HER2-Positive Breast Cancer. Int. J. Mol. Sci. 2022, 23, 15515.
https://doi.org/10.3390/ijms232415515
AMA Style
Crocamo S, Binato R, dos Santos EC, de Paula B, Abdelhay E.
Translational Results of Zo-NAnTax: A Phase II Trial of Neoadjuvant Zoledronic Acid in HER2-Positive Breast Cancer. International Journal of Molecular Sciences. 2022; 23(24):15515.
https://doi.org/10.3390/ijms232415515
Chicago/Turabian Style
Crocamo, Susanne, Renata Binato, Everton Cruz dos Santos, Bruno de Paula, and Eliana Abdelhay.
2022. "Translational Results of Zo-NAnTax: A Phase II Trial of Neoadjuvant Zoledronic Acid in HER2-Positive Breast Cancer" International Journal of Molecular Sciences 23, no. 24: 15515.
https://doi.org/10.3390/ijms232415515
APA Style
Crocamo, S., Binato, R., dos Santos, E. C., de Paula, B., & Abdelhay, E.
(2022). Translational Results of Zo-NAnTax: A Phase II Trial of Neoadjuvant Zoledronic Acid in HER2-Positive Breast Cancer. International Journal of Molecular Sciences, 23(24), 15515.
https://doi.org/10.3390/ijms232415515